相似文献
1
Proceedings: Preliminary observations on the human pharmacology of I.C.I. 66082 in normal volunteers.
Br J Pharmacol. 1973 Sep;49(1):154P-155P.
2
Proceedings: Antagonism by ICI 66082 of the effects of electrical stimulation on the right ansa subclavia of the dog.
Br J Pharmacol. 1974 Mar;50(3):457P-458P.
3
Proceedings: The efferent pathway of the reflex increase in heart rate produced by stimulation of left arterial receptors.
J Physiol. 1974 Oct;242(2):79P-80P.
4
Assessment of beta-blocking activity of trimepranol in man.
Int J Clin Pharmacol Biopharm. 1978 Jun;16(6):279-84.
5
Proceedings: Relationship between the pharmacokinetic and pharmacodynamic properties of the beta-receptor antagonists alprenolol and metoprolol.
Acta Pharm Suec. 1974 Dec;11(6):660.
6
Letter: Beta receptors and renin release.
N Engl J Med. 1974 Jan 31;290(5):284. doi: 10.1056/NEJM197401312900516.
7
[Clinical pharmacology of trimepranol (pharmacokinetic informations and effects on heart rate in healthy individuals)].
Vnitr Lek. 1976 Nov;22(11):1102-9.
8
[Structure-activity relationship of phenoxyalkanolamine derivatives with selective beta 1-receptor blocking action].
Pharmazie. 1975 Oct;30(10):638-42.
9
Initial clinical experience with I.C.I. 66.082, a new beta-adrenergic blocking agent, in hypertension.
Acta Med Scand. 1973 Dec;194(6):549-50. doi: 10.1111/j.0954-6820.1973.tb19489.x.
10
Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris.
Br Heart J. 1974 Dec;36(12):1194-1200. doi: 10.1136/hrt.36.12.1194.
引用本文的文献
1
The influence of urine pH on the renal excretion of ICI 66082 in man.
Br J Clin Pharmacol. 1974 Dec;1(6):513-4. doi: 10.1111/j.1365-2125.1974.tb01705.x.
2
A simple spectrophotofluorometric method for the measurement of I.C.I. 66082 in plasma and urine.
Br J Clin Pharmacol. 1974 Feb;1(1):84-6. doi: 10.1111/j.1365-2125.1974.tb00213.x.
3
The distribution of propranolol, pindolol and atenolol between human erythrocytes and plasma.
Br J Clin Pharmacol. 1981 Oct;12(4):543-8. doi: 10.1111/j.1365-2125.1981.tb01263.x.
4
Clinical pharmacokinetics of atenolol--a review.
Eur J Drug Metab Pharmacokinet. 1982;7(2):81-91. doi: 10.1007/BF03188723.
5
An investigation into the cardiac and pulmonary beta-adrenoceptor blocking activity of ICI 66,082 in man.
Br J Clin Pharmacol. 1975 Apr;2(2):151-7. doi: 10.1111/j.1365-2125.1975.tb01570.x.
6
Comparative potency of atenolol and propranolol as beta-adrenergic blocking agents in man.
Eur J Clin Pharmacol. 1976 Sep 30;10(5):297-303. doi: 10.1007/BF00565617.
7
8
Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.
Drugs. 1979 Jun;17(6):425-60. doi: 10.2165/00003495-197917060-00001.
9
Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
Clin Pharmacokinet. 1976;1(4):233-63. doi: 10.2165/00003088-197601040-00001.
10
Hypertension: which beta-blocker?
Drugs. 1976 Dec;12(6):412-14. doi: 10.2165/00003495-197612060-00002.
本文引用的文献
1
The blocking effects of propranolol, practolol and ICI-66082 on the peripheral vascular responses to isoprenaline.
Br J Pharmacol. 1973 Jun;48(2):342P-343P.
2
A new type of cardioselective adrenoceptive blocking drug.
Br J Pharmacol. 1973 Jun;48(2):340P.
Zotero 插件